NCT04179370

Brief Summary

Vitamin D deficiency remains a global public health issue (Wilson 2017). In the United Kingdom (UK). There is a lack of research looking at vitamin D status of the British African-Caribbean population. This population is particularly at risk to vitamin D deficiency due to possessing a skin type which hinders the production of vitamin D in the skin. Further, due to the geographical location of the UK, there is reduced ability to produce vitamin D due to the low sun exposure (Libon 2013 ). Our main source of vitamin D is through skin exposure to the sun. In the UK, the UV radiation is only strong enough in April-September (Wilson 2017) for the production of vitamin D to occur. In winter months, vitamin D needs to be consumed in food or supplement form. Vitamin D is essential for healthy bones and is associated with reduced risk of certain cancers and immune disorders (Wilson 2017). There is strong epidemiological evidence linking low vitamin D status with diabetes, cardiovascular disease, osteoporosis, osteoarthritis and some cancers (NatCen 2018). This observational study will aim to determine the vitamin D status of British Afro-Caribbean women, as well as determine the effects of sun exposure, dietary vitamin D intake, muscular strength, lifestyle and anthropometrical (height, weight etc.) factors have on vitamin D status. The study will be conducted at the University of Surrey. The study will take place in Autumn and winter 2019/2020 and a repeat study in Spring 2020. Each participant will require two visits to the university, each session will take approximately 2 hours. The study is funded by the University of Surrey. The findings of this study may lead to strategies for improving vitamin D status in this population, as well as improving guidelines to assist darker-skinned people regarding sunlight exposure in high latitudes.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 20, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 27, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

February 7, 2020

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

December 16, 2024

Status Verified

December 1, 2024

Enrollment Period

5.1 years

First QC Date

November 20, 2019

Last Update Submit

December 11, 2024

Conditions

Keywords

vitamin D OR 25(OH)DAfrican-Caribbean OR Afro-Caribbean

Outcome Measures

Primary Outcomes (11)

  • Vitamin D (serum 250HD) status

    A blood sample will be taken from participants. This will be analysed using liquid chromatography tandem mass spectroscopy (LC-MS)

    One measurement at baseline

  • Change in vitamin D status

    A blood sample will be taken from participants. This will be analysed using liquid chromatography tandem mass spectroscopy (LC-MS)

    The first measurement will be performed in winter 2020, with a repeat measurement approximately 3 months later in spring 2020.

  • Bone mineral composition

    Peripheral computed tomography (pQct) scan

    One measurement at baseline

  • Dual energy X-ray absorptiometry (DEXA) of whole body

    Assess bone mineral density

    One measurement at baseline

  • Dual energy X-ray absorptiometry (DEXA) of femoral head

    Assess fracture risk

    One measurement at baseline

  • Change in blood bone marker

    P1NP (bone markers) will be measured from blood

    The first measurement will be performed in winter 2020, with a repeat measurement approximately 3 months later in spring 2020.

  • Change in blood bone marker

    CTX (bone marker) will be measured from blood

    The first measurement will be performed in winter 2020, with a repeat measurement approximately 3 months later in spring 2020.

  • Vitamin D intake

    Vitamin D intake will be measured through a 4-day food diary which participants will fill out for 4 day at home after the study

    One measurement at baseline

  • Change in vitamin D intake

    Vitamin D intake will be measured through a 4-day food diary which participants will fill out for 4 day at home after the study

    The first measurement will be performed in winter 2020, with a repeat measurement approximately 3 months later in spring 2020.

  • Sun exposure

    sun exposure will be measured by a dosimeter which measures UVB exposure. Participants wear this like a badge, for 4 days after the study

    One measurement at baseline

  • Change in sun exposure from winter to spring

    sun exposure will be measured by a dosimeter which measures UVB exposure. Participants wear this like a badge, for 4 days after the study

    The first measurement will be performed in winter 2020, with a repeat measurement approximately 3 months later in spring 2020.

Secondary Outcomes (26)

  • Anthropometrical measurements - weight

    One measurement at baseline

  • Anthropometrical measurements - change in weight

    The first measurement will be performed in winter 2020, with a repeat measurement approximately 3 months later in spring 2020.

  • Anthropometrical measurements - height

    One measurement at baseline

  • Anthropometrical measurements - Hip circumference

    One measurement at baseline

  • Anthropometrical measurements - waist circumference

    One measurement at baseline

  • +21 more secondary outcomes

Interventions

N/A - no intervention. Observational study.

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsEligibility based on gender
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population is women aged over 18, who are not in menopause. Healthy women who have African-Caribbean ancestry, and have lived in the UK for more than 2 months are eligible.

You may qualify if:

  • Women
  • British African-Caribbean Self-reported Having African ancestral origin and migrated via the Caribbean islands, or having at least one parent with African ancestral origin that migrated via the Caribbean
  • Living in England for \>2 months
  • Aged 18-35 or \>55 years
  • No significant health issues
  • Pre-menopausal (regular menstrual periods) or Post-menopausal (menstrual periods stopped for longer than 12 consecutive months)
  • BMI 18-30kg/m2

You may not qualify if:

  • Women in perimenopause or menopause
  • Pregnant or planning pregnancy during study period
  • Hypercalcaemia (\>2.5mmol/L) - assessed and excluded at baseline
  • Currently receiving treatment for medical conditions that are likely to affect vitamin D metabolism (osteoporosis, hormone replacement therapy, anti-estrogens treatment, antiepileptic drugs and breast cancer treatment)
  • Regular use of sun beds
  • Having a sun holiday one month prior to commencing study or plans for a sun holiday for more than 4 weeks within the study period
  • Women who take vitamin D or calcium supplements (or multivitamin supplements that contain these vitamins) - If potential participant agrees to stop supplement use to join the study, a wash-out period of 8 weeks prior to commencing the study is acceptable
  • Living in England for less than 2 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Surrey

Guildford, GU27XH, United Kingdom

RECRUITING

Related Publications (5)

  • Natcen.ac.uk. (2018). NatCen Social Research. [online] Available at: http://www.natcen.ac.uk/news-media/press-releases/2018/january/natcen-and-mrc-epidemiology-unit-cambridge-to-deliver-national-diet-and-nutrition-survey/ [Accessed 16 July. 2019].

    BACKGROUND
  • Sturges, M. & Cannell, JJ (2018). Meta-analysis questions relationship between vitamin D and bone health among the elderly. [online] The Vitamin D Council Blog & Newsletter, January 23, 2018 [Accessed 16 July. 2019].

    BACKGROUND
  • Wall, BF, Haylock, R, Jansen, JTM, Hillier, MC, Hart, D, Shrimpton PC (2011). Radiation Risks from Medical X-ray Examinations as a Function of the Age and Sex of the Patient. [online] https://pdfs.semanticscholar.org/d90f/22c2c119c618c6822eb094087464e5ca3c4b.pdf [Accessed 7 October 2019)

    BACKGROUND
  • Wilson LR, Tripkovic L, Hart KH, Lanham-New SA. Vitamin D deficiency as a public health issue: using vitamin D2 or vitamin D3 in future fortification strategies. Proc Nutr Soc. 2017 Aug;76(3):392-399. doi: 10.1017/S0029665117000349. Epub 2017 Mar 28.

    PMID: 28347378BACKGROUND
  • Libon F, Cavalier E, Nikkels AF. Skin color is relevant to vitamin D synthesis. Dermatology. 2013;227(3):250-4. doi: 10.1159/000354750. Epub 2013 Oct 17.

    PMID: 24134867BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

A blood sample will be taken from participants and will include: * serum 25OHD, calcium and albumin, P1NP, CTX, lipid profile, micronutrient status * PTH plasma, blood glucose level * Whole Blood DNA

MeSH Terms

Conditions

Vitamin D Deficiency

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 20, 2019

First Posted

November 27, 2019

Study Start

February 7, 2020

Primary Completion

March 31, 2025

Study Completion

March 31, 2025

Last Updated

December 16, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Anonymised data from participants will be shared with researchers from partner universities (University of Surrey, University of Wollongong, University of Sao Paul and North Carolina State University)

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Project data will be held for at least 6 years and all research data for at least 10 years in accordance with University policy and in accordance with the {UK} Data Protection Act (2018)
Access Criteria
Anoymised data only. Data will be shared virtually with those in the research teams at partner universities.

Locations